Skip to main content
NIH funding notice RFA-HL-14-004

Ancillary Studies in Clinical Trials (R01)

Closed on May 23, 2014.

Posted
September 28, 2012
Close date
May 23, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
14
14 new
Median first-year cost
$403,438
$5,796,946 in all
Institutions
13
14 contact PIs
Patents
1
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. NATIONAL JEWISH HEALTH2
  2. BRIGHAM AND WOMEN'S HOSPITAL1
  3. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  4. EMORY UNIVERSITY1
  5. FRED HUTCHINSON CANCER RESEARCH CENTER1

and 8 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-I (O1))8
  2. Special Emphasis Panel (ZHL1 CSR-I (F2))4
  3. Special Emphasis Panel (ZHL1 CSR-I (M1))2
14 awards under RFA-HL-14-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2015Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD1R01HL125169-01A1Hanes, Justin S.Neptune, Enid RJOHNS HOPKINS UNIVERSITY, MDFirst-year cost $449,417Study section ZHL1
FY2015Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients1R01HL126589-01Ramsey, Scott D.Saber, WaelFRED HUTCHINSON CANCER RESEARCH CENTER, WAFirst-year cost $421,094Study section ZHL1
FY2015SPLUNC1 in Severe Asthma1R01HL125128-01A1Chu, Hong WDi, Yuanpu PeterUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $405,084Study section ZHL1
FY2015Genetics of Smoke-Altered LTA4H in COPD1R01HL126596-01Blalock, J EdwinCastaldi, PeterGaggar, AmitUNIVERSITY OF ALABAMA AT BIRMINGHAM, ALFirst-year cost $401,792Study section ZHL1
FY2015Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency1R01HL126600-01Hamzeh, NabeelO'Connor, Brian PNATIONAL JEWISH HEALTH, COFirst-year cost $393,891Study section ZHL1
FY2015Blood Based Biomarkers of Injury and Outcome in the Prehospital TXA for TBI Trial1R01HL126585-01Rowell, SusanOREGON HEALTH & SCIENCE UNIVERSITY, ORFirst-year cost $388,992Study section ZHL1
FY2015Nocturnal Rostral Fluid Shifts In Stroke Patients With Sleep Apnea1R01HL123379-01A1Brown, Devin LLisabeth, Lynda DUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $377,615Study section ZHL1
FY2015Contribution of neutrophils to early airway disease in cystic fibrosis children1R01HL126603-01Tirouvanziam, Rabindra Marie-JeanEMORY UNIVERSITY, GAFirst-year cost $350,489Study section ZHL1
FY2014CIAO-ISCHEMIA - Resubmission - 11R01HL119153-01A1Reynolds, Harmony R.NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NYFirst-year cost $490,220Study section ZHL1
FY2014Effect of Low Dose Methotrexate on Arterial Inflammation in HIV1R01HL122177-01A1Tawakol, Ahmed AMASSACHUSETTS GENERAL HOSPITAL, MAFirst-year cost $451,313Study section ZHL1
FY2014Anti-inflammatory Therapy with Low Dose Methotrexate for Reduction of PAD1R01HL122158-01A1Pradhan, Aruna DasBRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $442,291Study section ZHL1
FY2014Effect of Blood Transfusion Practices on Cerebral and Somatic Oximetry1R01HL122167-01A1Chock, ValerieSTANFORD UNIVERSITY, CAFirst-year cost $428,508Study section ZHL1
FY2014PTSD, Medication Adherence, and Prognosis after Acute Coronary Syndromes1R01HL123368-01Kronish, Ian MatthewCOLUMBIA UNIVERSITY HEALTH SCIENCES, NYFirst-year cost $399,990Study section ZHL1
FY2014Improved Prediction of Response to Asthma Medication Using Small Molecules1R01HL123385-01A1Reisdorph, Nichole ANATIONAL JEWISH HEALTH, COFirst-year cost $396,250Study section ZHL1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

1 patent names 1 of the 14 funded projects.

  1. US 11,286,287 (opens the patent at USPTO, a PDF, in a new tab)NOVEL ANTIMICROBIAL AND ANTI-CANCER THERAPYGranted March 29, 2022 to University of Pittsburgh—Of the Commonwealth System of Higher EducationR01HL125128 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-HL-14-004: Ancillary Studies in Clinical Trials (R01) | ScienceDex | ConductScience